News Headline Summary

For Vivus (VVUS): Drug makers looking to tap the obesity market face challenges from the cumbersome prescription process

- Sales of Co.'s Qsymia have already been hurt since the launch in December.
- Co. has asked the FDA to expand distribution to a number of retail pharmacies and expects a decision by April.

Reaction details:

- No immediate reaction to the news, last trade at USD 12.96 (-3.35%)

Print 15:13, 02 Jan 2013 - US Equities - Source: B4THESTREET.COM